ArticleAnnals of the rheumatic diseases2022

Baricitinib further enhances disease-modifying effects by uncoupling the link between disease activity and joint structural progression in patients with rheumatoid arthritis.

Pedro Lopez-Romero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.